Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.8491524369.0174
Domestic EquitiesTorrent Pharmaceuticals Ltd.6.0819131305.0551
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.696467234.7347
Domestic EquitiesCipla Ltd.5.6763312184.7180
Domestic EquitiesDivi's Laboratories Ltd.4.736161583.9365
Domestic EquitiesNeuland Laboratories Ltd.4.505924683.7452
Domestic EquitiesFortis Healthcare Ltd.4.4778421023.7218
Domestic EquitiesAurobindo Pharma Ltd.4.4551313013.7029
Domestic EquitiesPiramal Pharma Ltd.4.31682083513.5880
Domestic EquitiesOnesource Specialty Pharma Ltd.3.8836178283.2279
Domestic EquitiesAbbott India Ltd.3.38039682.8096
Domestic EquitiesAlkem Laboratories Ltd.3.317950082.7577
Domestic EquitiesConcord Biotech Ltd.3.1527194742.6204
Domestic EquitiesArtemis Medicare Services Ltd.3.0500935292.5351
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.9368119942.4410
Domestic EquitiesNavin Fluorine International Ltd.2.931741162.4367
Domestic EquitiesIPCA Laboratories Ltd.2.8344166042.3559
Domestic EquitiesGland Pharma Ltd.2.7660133512.2990
Domestic EquitiesMetropolis Healthcare Ltd.2.6495114172.2022
Domestic EquitiesDr Agarwal's Health Care Ltd.2.4204395762.0118
Domestic EquitiesMankind Pharma Ltd.2.266685771.8839
Domestic EquitiesSyngene International Ltd.2.2134282601.8397
Domestic EquitiesGlobal Health Ltd.2.1342149521.7739
Domestic EquitiesMax Healthcare Institute Ltd.2.1093167751.7532
Domestic EquitiesAnthem Biosciences Ltd.1.7998229611.4959
Domestic EquitiesAcutaas Chemicals Ltd.1.702983021.4154
Domestic EquitiesVinati Organics Ltd.1.671387411.3891
Total 98.0163 81.4680
Cash & Cash Equivalents and Net AssetsTreps2.3171 1.9259
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.3334 -0.2771
Total 1.9837 1.6488
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.